Aztreonam and Erythromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aztreonam (aztreonam) and Erythromycin (erythromycin). Common drug interactions include eosinophilia among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Aztreonam and Erythromycin. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Aztreonam?

Aztreonam has active ingredients of aztreonam. eHealthMe is studying from 3,054 Aztreonam users. Check the latest studies of Aztreonam.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.



On Jul, 09, 2026

24 people who take Aztreonam and Erythromycin together, and have interactions are studied.

Aztreonam and Erythromycin drug interactions.

What are the common drug interactions of Aztreonam and Erythromycin, by gender? *:

female:

  1. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  2. Hepatitis acute
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  5. Abscess (pus)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Breast pain
  8. Cardiac arrest
  9. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  10. Lactic acidosis (low ph in body tissues)

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Parainfluenzae virus infection
  5. Platelet count decreased
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Herpes simplex ophthalmic (eye infection is caused by a type of herpes simplex virus)
  10. Pneumonia

What are the common drug interactions of Aztreonam and Erythromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Respiratory distress (difficulty in breathing)
  4. Acute respiratory failure
  5. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  6. Herpes simplex ophthalmic (eye infection is caused by a type of herpes simplex virus)
  7. Pneumonia
  8. Pneumonia fungal
  9. Pneumonia viral
  10. Pulmonary haemorrhage (acute bleeding from the lung)

30-39:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  3. Hepatitis acute
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Drug hypersensitivity
  6. Hypersensitivity
  7. Nausea (feeling of having an urge to vomit)
  8. Vomiting

40-49:

n/a

50-59:

n/a

60+:

  1. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
  2. Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
  3. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  4. Abscess (pus)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Breast pain
  7. Cardiac arrest
  8. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  9. Lactic acidosis (low ph in body tissues)
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 4 people, 16.67%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 16.67%
  3. Depressed Mood: 3 people, 12.50%
  4. Abdominal Pain Upper: 3 people, 12.50%
  5. Biliary Sepsis: 3 people, 12.50%
  6. Blepharitis (chronic inflammation of the eyelid): 3 people, 12.50%
  7. Breast Cancer: 3 people, 12.50%
  8. Breast Cancer Metastatic: 3 people, 12.50%
  9. Cholecystitis Acute (rapid infection of gallbladder): 3 people, 12.50%
  10. Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Aztreonam and Erythromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aztreonam and Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aztreonam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aztreonam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam and erythromycin (the active ingredients of Aztreonam and Erythromycin, respectively), and Aztreonam and Erythromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: